STAT

Ebola outbreak in DRC sets up another test for experimental treatments

A handful of experimental therapeutics may be available to try to quell the world's latest Ebola outbreak.
An aid worker from the Democratic Republic of Congo gets vaccinated against Ebola in Mbandaka in May.

In the world of Ebola outbreaks, lucky breaks are few and far between. But it appears the Democratic Republic of the Congo may have caught a small one in its latest go-round with the dangerous disease.

And it might also give the world another shot at testing an experimental Ebola vaccine.

Officials in the DRC said Thursday that testing has shown that the province in the northeast of the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks